PRIMARY PREVENTION OF HYPERTENSION
作者： TrevorC. Beard
DOI: 10.1016/S0140-6736(83)92165-7
关键词: Intensive care medicine 、 Primary prevention 、 Medicine
摘要:
sci-hub.se 参考文章(5)
Lars Wilhelmsen, Göran Berglund, Dag Elmfeldt, Hans Wedel, β-Blockers versus saluretics in hypertension Preventive Medicine. ,vol. 10, pp. 38- 49 ,(1981) , 10.1016/0091-7435(81)90004-9
IM Stewart, beta-Adrenoceptor blockade and the incidence of myocardial infarction during treatment of severe hypertension. British Journal of Clinical Pharmacology. ,vol. 13, pp. 91- 93 ,(1982) , 10.1111/J.1365-2125.1982.TB01343.X
D.G. Beevers, J.H. Johnston, H. Larkin, P. Davies, Clinical Evidence that β-Adrenoceptor Blockers Prevent More Cardiovascular Complications than Other Antihypertensive Drugs Drugs. ,vol. 25, pp. 326- 330 ,(1983) , 10.2165/00003495-198300252-00095
J A Trafford, C R Horn, H O'Neal, R McGonigle, L Halford-Maw, R Evans, Five year follow-up of effects of treatment of mild and moderate hypertension. BMJ. ,vol. 282, pp. 1111- 1113 ,(1981) , 10.1136/BMJ.282.6270.1111
Dollery Ct, Hypertension and new antihypertensive drugs: clinical perspectives. Federation proceedings. ,vol. 42, pp. 207- ,(1983)